Op deze pagina vindt u het laatste nieuws uit de wereld van klinisch onderzoek! Voor het nieuwsoverzicht (nieuwsfeed) op deze pagina worden van een aantal organisaties, instanties, bedrijven en personen de RSS feeds gevolgd. De RSS feeds worden elke 5 – 10 minuten ververst en op deze pagina weergegeven. Voor een overzicht van alle nieuwsbronnen, klik hier.
Omdat de plug-in die ik voor deze pagina gebruik niet overweg kan met de RSS feeds van een aantal organisaties, instanties, bedrijven en personen heb ik een alternatieve pagina ingericht om de RSS feeds van deze organisaties, instanties, bedrijven en personen toch weer te kunnen geven. Klik hier om het alternatieve nieuwsoverzicht te raadplegen.
Meer nieuws en actualiteiten:
- Alternatief nieuwsoverzicht
- Archief Nieuwsbrief voor Goede Onderzoekspraktijken
- Uitgelicht & Gespot op internet
Nieuwsfeed
- Weekend reads: A retraction for top cancer researcher; paper mill ads paired to IEEE proceedings; about that study on ChatGPT and learning
- Weekend reads: A retraction for top cancer researcher; paper mill ads paired to IEEE proceedings; about that study on ChatGPT and learning
- Generic Drug User Fee Amendments
- Artificial Intelligence for Drug Development
- External Engagements with FDA for Artificial Intelligence in Drug Development
- 2026 Biological License Application Approvals
- Novel Drug Approvals for 2026
- One Way to Combat Ageism in Healthcare
- Does mRNA Require IBC Review? How the NIH Guidelines Apply to Clinical Trials
- FDA works to protect consumers from potentially harmful OTC skin lightening products
- OTP Events, Meetings, and Workshops
- What's New Related to Drugs
- Oncology (Cancer)/Hematologic Malignancies Approval Notifications
- FDA approves vepdegestrant for ER-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer
- FDA Permits Expanded Access for Investigational Pancreatic Cancer Drug
- ROTARIX
- NEJM retracts case study for AI-manipulated imagery
- Untitled Letters
- Generic Drug Facilities, Sites and Organization Lists
- Sponsor’s Guide to IRB Approval (Part III): Building an IRB-Ready Informed Consent
- Withdrawn | Cancer Accelerated Approvals
- Ongoing | Cancer Accelerated Approvals
- Drug Trials Snapshot: TRYNGOLZA
- Human Drug Compounding Policies and Rules
- Drug Trials Snapshot: ALYFTREK
- Drug Trials Snapshots: DATROWAY
- Drug Trials Snapshot: ROMVIMZA
- Drug Trials Snapshots: QFITLIA
- Drug Trials Snapshot: VANRAFIA
- Drug Trials Snapshot: AVMAPKI FAKZYNJA CO-PACK
- The Industry Talks Access — Fabian Sandoval Builds It
- The RW Daily: Are AI chatbots infiltrating online survey data? Not yet, study says. And: Study claiming ChatGPT improves learning has been retracted.
- A 360 Degree Qualitative Ethical Assessment of Reporting Patient Reported Outcomes
- Patient Listening Session Summaries
- Drug Trials Snapshots: AGAMREE
- Public Webinar: FDA Review of Biologics License Applications for Blood and Source Plasma - 05/12/2026
- Drug Trials Snapshot: TALVEY
- Drug Trials Snapshots: ELREXFIO
- Drug Trials Snapshots: VEOPOZ
- Drug Trials Snapshots: OJJAARA
- Drug Trials Snapshots: EXXUA
- Drug Trials Snapshots: POMBILITI
- Drug Trials Snapshots: ZILBRYSQ
- Drug Trials Snapshots: BIMZELX
- Verified Clinical Benefit | Cancer Accelerated Approvals
- Are AI chatbots infiltrating online survey data? Not yet, says new study
- Lancering informatiebrief IVO uitgesteld
- Vaccines and Related Biological Products Advisory Committee March 12, 2026 Meeting Announcement - 03/12/2026
- Revised CTIS transparency rules & historical trials: quick guide for users
- Annex I - Guidance document on how to approach the protection of personal data and commercially confidential information while using the Clinical Trials Information System (CTIS) Version 2.2
